StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
GSK plc
LSE:GSK.L
Sector
Location
Market Cap
USD 77.29 B
Share Price
USD 19.13
Avg Daily Volume
9,958,476
Change (1 day)
0.71%
Change (1 year)
-2.91%
Change (YTD)
13.53%
GSK plc Return on Equity (ROE) for the year ending December 31, 2024: 18.84%
GSK plc Return on Equity (ROE) is 18.84% for the year ending December 31, 2024, a -48.99% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
-
GSK plc Return on Equity (ROE) for the year ending December 31, 2023 was 36.92%, a -20.48% change year over year.
-
GSK plc Return on Equity (ROE) for the year ending December 31, 2022 was 46.43%, a 59.42% change year over year.
-
GSK plc Return on Equity (ROE) for the year ending December 31, 2021 was 29.13%, a -26.10% change year over year.
-
GSK plc Return on Equity (ROE) for the year ending December 31, 2020 was 39.41%, a 1.68% change year over year.
Competitors
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Cencora, Inc.
USD 297.06
COR
+1.85
0.63%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.98
600276.SS
+0.04
0.52%
Takeda Pharmaceutical Company Limited
USD 29.87
4502.T
+0.36
1.22%
Haleon plc
USD 4.93
HLN.L
-0.02
-0.48%
Daiichi Sankyo Company, Limited
USD 23.02
4568.T
+0.44
1.93%
Ucb S.A.
USD 201.26
UCB.BR
+1.45
0.73%
BeOne Medicines Ltd.
USD 252.14
ONC
+1.84
0.73%
Hansoh Pharmaceutical Group Company Limited
USD 4.19
3692.HK
+0.04
0.96%
Key Data
| Date | Return on Equity (ROE) | Return on Assets (ROA) | Revenue Per Share | Free Cash Flow Per Share |
|---|
Competitors
Eli Lilly and Company
USD 799.34
LLY
+6.33
0.80%
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
Cencora, Inc.
USD 297.06
COR
+1.85
0.63%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.98
600276.SS
+0.04
0.52%
Takeda Pharmaceutical Company Limited
USD 29.87
4502.T
+0.36
1.22%
Haleon plc
USD 4.93
HLN.L
-0.02
-0.48%
Daiichi Sankyo Company, Limited
USD 23.02
4568.T
+0.44
1.93%
Ucb S.A.
USD 201.26
UCB.BR
+1.45
0.73%
BeOne Medicines Ltd.
USD 252.14
ONC
+1.84
0.73%
Hansoh Pharmaceutical Group Company Limited
USD 4.19
3692.HK
+0.04
0.96%